| Íåâðîòè÷åñêèå, ñâÿçàííûå ñî ñòðåññîì è ñîìàòîôîðìíûå ðàññòðîéñòâà (F40-F48) | |
| Ôîáè÷åñêèå òðåâîæíûå ðàññòðîéñòâà | |
| ÀÍÀÔÐÀÍÈË | NOVARTIS PHARMA AG |
| ÀÒÀÐÀÊÑ® | UCB S.A. PHARMA SECTOR |
| ÃÐÀÍÄÀÊÑÈÍ | EGIS PHARMACEUTICALS Ltd. |
| ÇÎËÎÔÒ | PFIZER |
| ËÎÐÀÔÅÍ | TARCHOMIN PHARMACEUTICAL WORKS POLFA S.A. |
| ÍÅÃÐÓÑÒÈÍ® | HEXAL AG |
| ÍÎÂÎ-ÏÀÑÑÈÒ® | IVAX-CR a.s. |
| ÏÀÊÑÈË | SmithKline Beecham Pharmaceuticals |
| ÏÈÐÀÇÈÄÎË® | ÄÀËÜÕÈÌÔÀÐÌ ÎÀÎ |
| ÐÅÊÑÅÒÈÍ | GEDEON RICHTER Ltd. |
| ÐÅËÀÍÈÓÌ | WARSAW PHARMACEUTICAL WORK POLFA |
| ÑÅÄÓÊÑÅÍ | ÃÅÄÅÎÍ ÐÈÕÒÅÐ-ÐÓÑ ÇÀÎ |
| ÑÅÄÓÊÑÅÍ | GEDEON RICHTER Ltd. |
| ÒÈÇÅÐÖÈÍ | EGIS PHARMACEUTICALS Ltd. |
| ÒÈÑÎÍ | ÂÅÐÎÔÀÐÌ ÇÀÎ |
| ÔËÞÀÍÊÑÎË | H.LUNDBECK A/S |